CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $55.28 ($552,800)
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $42.83 ($428,300)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $45.16 ($451,600)
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B5 Offering Prospectus
Page 16 of 21 · 416 filings